# A Study to Test How Verducatib is Taken up in the Body of Healthy Chinese Participants

> **NCT07531628** · PHASE1 · NOT_YET_RECRUITING · sponsor: **Boehringer Ingelheim** · enrollment: 12 (estimated)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Verducatib

## Key facts

- **NCT ID:** NCT07531628
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-07-13
- **Primary completion:** 2026-08-10
- **Final completion:** 2026-10-14
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2026-04-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07531628

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07531628, "A Study to Test How Verducatib is Taken up in the Body of Healthy Chinese Participants". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07531628. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*